Genertec Universal Medical Group Co (2666.HK) Stock Price

Genertec Universal Medical Group Co Price

HKEX·CLOSED
3.96CNY-0.05 (-1.21 %)
Market closed

Over the last 13 years Genertec Universal Medical Group Co grew revenue by 27.9% annually, reaching 16.95 B CNY. Earnings per share have grown at 13.2% per year over the last 12 years. For Genertec Universal Medical Group Co, the net margin of 15.2% is down versus 20.4% a few years ago. At today's price the dividend yield works out to roughly 8.83%. The payout ratio is around 24% of earnings. The dividend has grown at 11.6% per year over the past 9 years. The consensus 12-month price target for Genertec Universal Medical Group Co is 7.01 CNY, about 76.9% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 4% above its 52-week low.

Genertec Universal Medical Group Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Genertec Universal Medical Group Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genertec Universal Medical Group Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genertec Universal Medical Group Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Genertec Universal Medical Group Co Stock Price History
DateGenertec Universal Medical Group Co Price
8/24/20263.96 CNY
8/21/20264.01 CNY
8/20/20264.00 CNY
8/19/20263.95 CNY
8/18/20263.97 CNY
8/17/20263.96 CNY
8/14/20263.99 CNY
8/13/20263.96 CNY
8/12/20263.98 CNY
8/11/20264.04 CNY
8/10/20264.02 CNY
8/7/20263.92 CNY
8/6/20263.90 CNY
8/5/20263.94 CNY
8/4/20263.95 CNY
8/3/20264.01 CNY
7/31/20264.22 CNY
7/30/20264.15 CNY
7/29/20264.15 CNY
7/28/20264.02 CNY
7/27/20264.06 CNY
7/24/20264.09 CNY
7/23/20264.16 CNY
7/22/20264.12 CNY
7/21/20264.13 CNY
7/20/20264.18 CNY
7/17/20264.15 CNY
7/16/20264.17 CNY
7/15/20264.12 CNY
7/14/20264.03 CNY
7/13/20263.97 CNY
7/10/20263.97 CNY
7/9/20263.93 CNY
7/8/20263.98 CNY
7/7/20263.94 CNY
7/6/20264.05 CNY
7/3/20264.01 CNY
7/2/20263.88 CNY
6/30/20263.85 CNY
6/29/20263.88 CNY
6/26/20263.82 CNY
6/25/20264.13 CNY
6/24/20264.11 CNY
6/23/20264.17 CNY
6/22/20264.23 CNY
6/18/20264.30 CNY
6/17/20264.40 CNY
6/16/20264.48 CNY
6/15/20264.59 CNY
6/12/20264.59 CNY
6/11/20264.52 CNY
6/10/20264.55 CNY
6/9/20264.47 CNY
6/8/20264.52 CNY
6/5/20264.51 CNY
6/4/20264.54 CNY
6/3/20264.56 CNY
6/2/20264.55 CNY
6/1/20264.54 CNY
5/29/20264.48 CNY
5/28/20264.50 CNY
5/27/20264.59 CNY
5/26/20264.63 CNY
5/22/20264.67 CNY
5/21/20264.67 CNY
5/20/20264.72 CNY
5/19/20264.75 CNY
5/18/20264.75 CNY
5/15/20264.83 CNY
5/14/20264.83 CNY
5/13/20264.83 CNY
5/12/20264.90 CNY
5/11/20264.95 CNY
5/8/20264.96 CNY
5/7/20265.01 CNY
5/6/20265.02 CNY
5/5/20264.89 CNY
5/4/20264.96 CNY
4/30/20265.02 CNY
4/29/20265.09 CNY
4/28/20265.02 CNY
4/27/20265.05 CNY
4/24/20265.10 CNY
4/23/20265.14 CNY
4/22/20265.11 CNY
4/21/20265.16 CNY
4/20/20265.11 CNY
4/17/20265.12 CNY
4/16/20265.09 CNY
4/15/20265.08 CNY
4/14/20265.05 CNY
4/13/20265.03 CNY
4/10/20265.08 CNY
4/9/20265.08 CNY
4/8/20265.15 CNY
4/2/20265.11 CNY
4/1/20265.16 CNY
3/31/20265.09 CNY
3/30/20265.13 CNY
3/27/20265.23 CNY
3/26/20265.11 CNY
3/25/20265.11 CNY
3/24/20265.05 CNY
3/23/20264.95 CNY
3/20/20265.14 CNY
3/19/20265.17 CNY
3/18/20265.26 CNY
3/17/20265.23 CNY
3/16/20265.23 CNY
3/13/20265.24 CNY
3/12/20265.28 CNY
3/11/20265.23 CNY
3/10/20265.34 CNY
3/9/20265.22 CNY
3/6/20265.39 CNY
3/5/20265.22 CNY
2/26/20265.43 CNY
2/25/20265.58 CNY
2/24/20265.56 CNY
2/23/20265.62 CNY
2/20/20265.40 CNY
2/16/20265.49 CNY
2/13/20265.45 CNY
2/12/20265.54 CNY
2/11/20265.60 CNY
2/10/20265.53 CNY
2/9/20265.49 CNY
2/6/20265.50 CNY
2/5/20265.56 CNY
2/4/20265.51 CNY
2/3/20265.50 CNY
2/2/20265.55 CNY
1/30/20265.53 CNY
1/29/20265.64 CNY
1/28/20265.53 CNY
1/27/20265.52 CNY
1/26/20265.45 CNY
1/23/20265.48 CNY
1/22/20265.58 CNY
1/21/20265.57 CNY
1/20/20265.58 CNY
1/19/20265.52 CNY
1/15/20265.65 CNY
1/14/20265.62 CNY
1/13/20265.60 CNY
1/12/20265.50 CNY
1/9/20265.52 CNY
1/8/20265.55 CNY
1/7/20265.52 CNY
1/6/20265.46 CNY
1/5/20265.49 CNY
1/2/20265.36 CNY
12/31/20255.36 CNY
12/30/20255.41 CNY
12/29/20255.45 CNY
12/24/20255.53 CNY
12/23/20255.62 CNY
12/22/20255.63 CNY
12/19/20255.54 CNY
12/18/20255.54 CNY
12/17/20255.62 CNY
12/16/20255.52 CNY
12/15/20255.64 CNY
12/12/20255.66 CNY
12/11/20255.62 CNY
12/10/20255.70 CNY
12/9/20255.66 CNY
12/8/20255.81 CNY
12/5/20255.79 CNY
12/4/20255.78 CNY
12/3/20255.80 CNY
12/2/20255.92 CNY
12/1/20255.70 CNY
11/28/20255.70 CNY
11/27/20255.74 CNY
11/26/20255.78 CNY
11/25/20255.81 CNY
11/24/20255.74 CNY
11/21/20255.73 CNY
11/20/20255.87 CNY
11/19/20255.90 CNY
11/18/20255.90 CNY
11/17/20255.95 CNY
11/14/20255.88 CNY
11/13/20256.01 CNY
11/12/20256.08 CNY
11/11/20255.99 CNY
11/10/20255.98 CNY
11/7/20255.97 CNY
11/6/20255.97 CNY
11/5/20255.93 CNY
11/4/20255.89 CNY
11/3/20255.85 CNY
10/31/20255.69 CNY
10/30/20255.62 CNY
10/28/20255.59 CNY
10/27/20255.68 CNY
10/24/20255.63 CNY
10/23/20255.62 CNY
10/22/20255.66 CNY
10/21/20255.62 CNY
10/20/20255.59 CNY
10/17/20255.52 CNY
10/16/20255.63 CNY
10/15/20255.55 CNY
10/14/20255.45 CNY
10/13/20255.53 CNY
10/10/20255.56 CNY
10/9/20255.59 CNY
10/8/20255.54 CNY
10/6/20255.60 CNY
10/3/20255.64 CNY
10/2/20255.67 CNY
9/30/20255.55 CNY
9/29/20255.53 CNY
9/26/20255.45 CNY
9/25/20255.50 CNY
9/24/20255.72 CNY
9/23/20255.70 CNY
9/22/20255.76 CNY
9/19/20255.82 CNY
9/18/20255.72 CNY
9/17/20255.72 CNY
9/16/20255.68 CNY
9/15/20255.67 CNY
9/12/20255.76 CNY
9/11/20255.83 CNY
9/10/20255.90 CNY
9/9/20255.90 CNY
9/8/20255.64 CNY
9/5/20255.58 CNY
9/4/20255.47 CNY
9/3/20255.60 CNY
9/2/20255.60 CNY
9/1/20255.65 CNY
8/29/20255.55 CNY
8/28/20255.51 CNY
8/27/20255.65 CNY
Access this data via the Eulerpool API
Get Free API Key

Genertec Universal Medical Group Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
11.16 B CNY
9.73 B CNY
2.27 B CNY
Jan 1, 2022
13.49 B CNY
12.04 B CNY
2.29 B CNY
Jan 1, 2023
15.92 B CNY
3.77 B CNY
2.46 B CNY
Jan 1, 2024
15.93 B CNY
3.60 B CNY
2.45 B CNY
Jan 1, 2025
16.95 B CNY
3.55 B CNY
2.58 B CNY
Jan 1, 2026 (e)
11.38 B CNY
3.67 B CNY
2.21 B CNY
Jan 1, 2027 (e)
11.72 B CNY
3.76 B CNY
2.29 B CNY
Jan 1, 2028 (e)
16.75 B CNY
3.90 B CNY
2.49 B CNY

Genertec Universal Medical Group Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 11:51 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITB CNY
EBIT MARGIN%
NET INCOMEB CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESB
20132014201520162017201820192020202120222023202420252026e2027e2028e
1.151.822.563.163.995.017.879.6111.1613.4915.9215.9316.9511.3811.7216.75
66.7258.2441.0523.3626.4125.4557.1122.1816.0520.8918.020.106.40-32.882.9942.89
100.0060.1759.6964.3463.6560.2846.10100.00100.00101.4233.4933.6034.8134.8134.8134.81
1.151.091.532.032.543.023.639.6111.1613.685.335.355.903.964.085.83
0.440.720.991.391.932.282.648.439.7312.043.773.603.553.673.763.90
38.0139.8338.7143.8648.3545.5933.5587.7487.1789.2923.6722.5920.9532.2632.0823.26
0.360.530.771.021.341.581.852.042.272.292.462.452.582.212.292.49
–46.1544.1732.5931.6617.7017.519.9911.490.627.70-0.335.01-14.403.639.15
–––0.130.170.240.270.290.310.360.340.390.350.360.370.38
––––30.7741.1812.507.416.9016.13-5.5614.71-10.262.862.782.70
1.271.011.701.721.721.721.721.722.072.082.082.012.032.032.032.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Genertec Universal Medical Group Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genertec Universal Medical Group Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genertec Universal Medical Group Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Genertec Universal Medical Group Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genertec Universal Medical Group Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Genertec Universal Medical Group Co stock margins

The Genertec Universal Medical Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genertec Universal Medical Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genertec Universal Medical Group Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
100.00 %
87.17 %
20.36 %
Jan 1, 2022
101.42 %
89.29 %
16.94 %
Jan 1, 2023
33.49 %
23.68 %
15.46 %
Jan 1, 2024
33.61 %
22.59 %
15.40 %
Jan 1, 2025
34.81 %
20.95 %
15.19 %
Jan 1, 2026 (e)
34.81 %
32.27 %
19.38 %
Jan 1, 2027 (e)
34.81 %
32.08 %
19.50 %
Jan 1, 2028 (e)
34.81 %
23.26 %
14.90 %

Genertec Universal Medical Group Co Stock Revenue, EBIT, Earnings per Share

The Genertec Universal Medical Group Co earnings per share therefore indicates how much revenue Genertec Universal Medical Group Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
5.39 CNY
4.70 CNY
1.10 CNY
Jan 1, 2022
6.48 CNY
5.79 CNY
1.10 CNY
Jan 1, 2023
7.64 CNY
1.81 CNY
1.18 CNY
Jan 1, 2024
7.93 CNY
1.79 CNY
1.22 CNY
Jan 1, 2025
8.37 CNY
1.75 CNY
1.27 CNY
Jan 1, 2026 (e)
5.66 CNY
1.81 CNY
1.10 CNY
Jan 1, 2027 (e)
5.83 CNY
1.86 CNY
1.14 CNY
Jan 1, 2028 (e)
8.33 CNY
1.92 CNY
1.24 CNY

Genertec Universal Medical Group Co business model & stock analysis

The company Genertec Universal Medical Group Co Ltd is a Chinese company specializing in the development, production, and sale of medical devices and products. The company was founded in 1993 and is headquartered in Beijing. Genertec Universal Medical Group Co Ltd has a broad business model, operating in various sectors focused on different medical areas. This includes medical technology, healthcare management, research and development, and medical services. In the medical technology sector, the company offers a wide range of medical devices and products. This includes ultrasound machines, EKG devices, endoscopes, ventilators, operating microscopes, X-ray machines, and many other medical devices. The devices and products of Genertec Universal Medical Group Co Ltd are known for their high quality and reliability and are in high demand by doctors and clinics worldwide. In the healthcare management sector, the company focuses on developing software and IT solutions for the medical sector. This includes specialized administrative programs for hospitals and medical practices that allow for efficient management and control of patient data. The company also places great emphasis on quality and innovation in this area. In the research and development sector, Genertec Universal Medical Group Co Ltd works closely with renowned universities and research institutions. The goal is to develop innovative medical devices and products that meet the requirements of modern medicine. The company has also achieved several important breakthroughs in this field in recent years and has established itself as an important partner in medical research. In addition to the mentioned sectors, Genertec Universal Medical Group Co Ltd also provides medical services. This includes offering specialized training and further education for doctors and medical personnel. The aim is to improve medical expertise in China and internationally and thus contribute to improving the health and well-being of patients worldwide. Overall, Genertec Universal Medical Group Co Ltd is an important player in the international medical industry. With innovative products and a clear focus on quality and reliability, the company has earned an excellent reputation in recent years and will continue to play an important role in the field of medical technology in the future.

Genertec Universal Medical Group Co SWOT Analysis

Strengths

Genertec Universal Medical Group Co Ltd possesses several strengths that contribute to its success:

  • Strong market presence in the medical industry
  • Diverse range of healthcare products and services
  • Established network of partnerships and collaborations
  • Advanced technological infrastructure
  • Experienced and skilled workforce

Weaknesses

Genertec Universal Medical Group Co Ltd faces the following weaknesses that need to be addressed:

  • Limited global reach compared to competitors
  • Relatively higher prices of some products
  • Dependency on specific suppliers
  • Less brand recognition compared to well-established players
  • Potential gaps in product innovation

Opportunities

Genertec Universal Medical Group Co Ltd has opportunities it can capitalize on:

  • Increasing demand for healthcare products and services globally
  • Growing aging population and healthcare needs
  • Potential for expansion into emerging markets
  • Advancements in technology for medical treatments
  • Rising focus on personalized medicine

Threats

Genertec Universal Medical Group Co Ltd faces the following threats that require attention:

  • Intense competition within the medical industry
  • Changing government regulations and policies
  • Economic instability affecting healthcare spending
  • Risk of counterfeit products impacting reputation
  • Uncertainty in global trade and supply chain disruptions

Genertec Universal Medical Group Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Genertec Universal Medical Group Co historical P/E ratio, EBIT multiple, and P/S ratio

Genertec Universal Medical Group Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Genertec Universal Medical Group Co shares outstanding

The number of shares of Genertec Universal Medical Group Co was 2.03 B in 2025. This indicates how many shares Genertec Universal Medical Group Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
2.07 B Stocks
Jan 1, 2022
2.08 B Stocks
Jan 1, 2023
2.08 B Stocks
Jan 1, 2024
2.01 B Stocks
Jan 1, 2025
2.03 B Stocks
Jan 1, 2026 (e)
2.03 B Stocks
Jan 1, 2027 (e)
2.03 B Stocks
Jan 1, 2028 (e)
2.03 B Stocks

Genertec Universal Medical Group Co Dividend History

11 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.36CNYYTD—1×
Jun 26, 20260.36CNY↑ 2.9%1/1
20250.35CNY↓ 10.3%1×
Jun 12, 20250.35CNY↑ 775.0%1/1
20240.39CNY↑ 14.7%2×
20230.34CNY↓ 5.6%1×
20220.36CNY↑ 16.1%1×
20210.31CNY↑ 6.9%1×
20200.29CNY↑ 7.4%1×
20190.27CNY↑ 12.5%1×
20180.24CNY↑ 41.2%1×
20170.17CNY↑ 30.8%1×

Genertec Universal Medical Group Co dividend history and estimates

In 2025, Genertec Universal Medical Group Co paid a dividend amounting to 0.35 CNY. Dividend means that Genertec Universal Medical Group Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.31 CNY
0.00 CNY
Jan 1, 2022
0.36 CNY
0.00 CNY
Jan 1, 2023
0.34 CNY
0.00 CNY
Jan 1, 2024
0.39 CNY
0.00 CNY
Jan 1, 2025
0.35 CNY
0.00 CNY
Jan 1, 2026
0.36 CNY
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
0.37 CNY
Jan 1, 2028 (e)
0.00 CNY
0.38 CNY

Genertec Universal Medical Group Co dividend payout ratio

In 2025, Genertec Universal Medical Group Co had a payout ratio of 23.64%. The payout ratio indicates the percentage of the company's profits that Genertec Universal Medical Group Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
24.27 %
Jan 1, 2022
28.15 %
Jan 1, 2023
24.72 %
Jan 1, 2024
24.64 %
Jan 1, 2025
23.64 %
Jan 1, 2026 (e)
32.81 %
Jan 1, 2027 (e)
32.63 %
Jan 1, 2028 (e)
30.80 %

Current Genertec Universal Medical Group Co forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
87.50 % (7)
Hold
12.50 % (1)
Sell
0.00 % (0)
12M Price Target
7.01
Last Price
3.96
Currency
CNY
12M Return Potential
76.87 %
LTM Return
0 %

Genertec Universal Medical Group Co shareholder structure

% Name
1.31008%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.83525%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.69447%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.49711%
State Street Global Advisors (US)
State Street Global Advisors (US)
0.27243%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
0.24519%
BlackRock Advisors (UK) Limited
BlackRock Advisors (UK) Limited

Genertec Universal Medical Group Co Beneficial Ownership Filings (SEC 13D/G)

Free Float
46.4%
Float Shares
-
Shares Outstanding
-

Genertec Universal Medical Group Co Executives and Management Board

11 members · avg. age 54 · 18 % women

WW

Mr. Wenbing Wang (49)

Chief Executive Officer, Executive Director · since 2021

4.34 M CNY

Management

WN

Ms. Wai Kam Ng

Company Secretary

–

Board of Directors

SC

Mr. Siu Lui Chow (64)

Non-Executive Independent Director

344,000.00 CNY
YL

Mr. Yinquan Li (70)

Non-Executive Independent Director

344,000.00 CNY
HC

Mr. Hiu Fung Chan (51)

Non-Executive Independent Director

170,000.00 CNY
ZX

Mr. Zhiming Xu (63)

Non-Executive Independent Director

170,000.00 CNY
SC

Mr. Shisu Chen (52)

Executive Chairman of the Board · since 2024

–
LW

Ms. Lin Wang (49)

Executive Director · since 2023

–

Frequently asked questions about Genertec Universal Medical Group Co

The business model of Genertec Universal Medical Group Co Ltd is focused on providing comprehensive medical solutions and services. With China as its core market, the company operates various business segments, including medical equipment and instrument manufacturing, medical technology research and development, medical service outsourcing, and medical investment and management. Genertec Universal Medical Group Co Ltd aims to leverage its expertise and resources to promote the development of China's medical industry, enhance healthcare services, and improve overall medical standards.

Genertec Universal Medical Group Co Ltd operates primarily in the healthcare and medical industry. With a focus on providing comprehensive medical services, the company offers a wide range of healthcare solutions including hospital management, medical equipment manufacturing, pharmaceutical research and development, and healthcare technology services. Genertec Universal Medical Group Co Ltd strives to contribute to the advancement of healthcare by delivering innovative and high-quality services to patients.

The main competitors of Genertec Universal Medical Group Co Ltd in the market include Beijing Tiantan Hospital, China National Pharmaceutical Group Corporation, and China Resources (Holdings) Co Ltd.

Genertec Universal Medical Group Co Ltd is a diversified healthcare company based in China. Established in 2001, the company has since grown to become one of the leading providers of medical products and services in the country. With a strong focus on innovation and quality, Genertec Universal Medical Group has continuously expanded its product portfolio and developed strategic partnerships with global medical technology companies. The company's commitment to improving healthcare standards in China has earned it a solid reputation within the industry. With a comprehensive range of medical devices, pharmaceuticals, and healthcare solutions, Genertec Universal Medical Group continues to contribute to the advancement of healthcare in China and beyond.

Some significant milestones achieved by Genertec Universal Medical Group Co Ltd include successful partnerships with leading healthcare organizations, expansion into international markets, and the development of innovative medical technologies. The company has established strategic alliances with renowned medical institutions, enhancing its research and development capabilities. Genertec Universal Medical Group Co Ltd has also experienced positive growth in global markets, reflecting its commitment to delivering high-quality medical products and services worldwide. Additionally, the company has introduced groundbreaking advancements in medical technology, improving patient care and revolutionizing the healthcare industry.

Genertec Universal Medical Group Co Ltd is primarily present in China.

Genertec Universal Medical Group Co Ltd embraces a set of core values and corporate philosophy that defines its operations. As a leading medical services company, Genertec Universal Medical Group Co Ltd prioritizes excellence, patient-centered care, and innovation in the healthcare industry. With a focus on providing high-quality medical services, the company upholds integrity, professionalism, and compassion in all its endeavors. By combining cutting-edge technology and advanced medical expertise, Genertec Universal Medical Group Co Ltd aims to enhance patient outcomes and contribute to the overall advancement of healthcare.

Analysts currently set an average price target of 7.01 CNY for the Genertec Universal Medical Group Co stock (median: 7.01 CNY), implying +76.9 % versus the latest price. The consensus is based on 8 analyst ratings.

Genertec Universal Medical Group Co Analyst Price Targets 2026

8 analysts currently rate the Genertec Universal Medical Group Co stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Genertec Universal Medical Group Co to generate revenue of 11.38 B CNY and earnings per share of 1.09 CNY.

Genertec Universal Medical Group Co Analyst Price Targets 2026

Converted at the current exchange rate, the Genertec Universal Medical Group Co share trades at 0.50 EUR (3.96 CNY).

The Genertec Universal Medical Group Co share (2666.HK) is listed on 3 stock exchanges, including: Frankfurt (5UM.F).

The company Genertec Universal Medical Group Co Ltd (GUMG) is an internationally operating company in the healthcare sector. It was founded in 2001 as a subsidiary of Genertec Holding Co Ltd, one of the leading Chinese energy companies. GUMG's business model is to offer comprehensive healthcare services that encompass all aspects of the healthcare industry. The company consists of various divisions, all contributing to the overall strategy of the healthcare company in different ways. One of GUMG's most important divisions is the hospital group. The company operates multiple hospitals in China and strives to provide high-quality medical services at the highest level. The hospitals offer specialized treatments for cancer patients, cardiovascular diseases, as well as neurology and orthopedics. Another important area of GUMG is research and development. The company has been investing in the research of new drugs and treatment methods for years, collaborating closely with renowned universities and research institutions in China. GUMG has already achieved several significant medical breakthroughs and continues its research activities to further improve healthcare in the future. In addition to hospitals and research, GUMG also heavily invests in the development of medical devices and technologies. The company operates its own research and development team that develops innovative products and brings them to the international market. Some of the products offered by GUMG include ultrasound devices, endoscopy equipment, EKG systems, and other medical instruments. Lastly, GUMG is also heavily involved in the training of medical professionals. The company operates its own training facilities and advocates for the improvement of medical education in China and other countries. GUMG aims to educate a new generation of physicians who are equipped to meet the challenges of modern healthcare. In summary, GUMG's business model is focused on providing comprehensive healthcare services. The company operates hospitals, conducts research and develops new medical products and technologies, and engages in the training of medical professionals. GUMG collaborates closely with universities and research institutions and strives to improve healthcare worldwide.

The expected revenue of Genertec Universal Medical Group Co is 11.38 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Genertec Universal Medical Group Co is 2.21 B CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Genertec Universal Medical Group Co is currently 3.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Genertec Universal Medical Group Co stock.

The price-to-sales ratio (P/S) of Genertec Universal Medical Group Co is currently 0.71. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Genertec Universal Medical Group Co stock.

The Eulerpool Quality Score for Genertec Universal Medical Group Co is 6/10.

The ISIN of Genertec Universal Medical Group Co is HK0000255361. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Genertec Universal Medical Group Co is A14V3L. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Genertec Universal Medical Group Co is 2666.HK. The ticker symbol is used to trade Genertec Universal Medical Group Co shares on the stock exchange.

Over the past 12 months, Genertec Universal Medical Group Co paid a dividend of 0.35 CNY . This corresponds to a dividend yield of about 8.83 %. For the coming 12 months, Genertec Universal Medical Group Co is expected to pay a dividend of 0.37 CNY.

The current dividend yield of Genertec Universal Medical Group Co is 8.83 %.

Genertec Universal Medical Group Co pays a dividend, distributed in the months of , , , .

Genertec Universal Medical Group Co paid dividends every year for the past 10 years.

For the upcoming 12 months, dividends amounting to 0.37 CNY are expected. This corresponds to a dividend yield of 9.36 %.

Genertec Universal Medical Group Co is assigned to the 'Health' sector.

In the year 2025, Genertec Universal Medical Group Co distributed 0.39 CNY as dividends.

The dividends of Genertec Universal Medical Group Co are distributed in CNY.

All fundamentals and in-depth analysis of Genertec Universal Medical Group Co

Our stock analysis for Genertec Universal Medical Group Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genertec Universal Medical Group Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Revenue→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Net Income→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co P/E→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co P/S→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co EBIT→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Dividend→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Directors Dealings→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Stocks→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Market capitalization→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Debt→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Liabilities→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Equity→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co AAQS→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Employees→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co ROE→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co ROA→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co ROCE→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co News→
Genertec Universal Medical Group Co Stock
Genertec Universal Medical Group Co Analyst Price Targets→

Health Stocks

Genesis Fertility Center PCLGeneReach BiotechnologyGenesis IBRC IndiaGeneral BiologicalsGeneSystem CoGenenta Science SpA ADRGenetic SignaturesGenematrixGenetic TechnologiesGeneluxGenetics Generation AdvancementGenelinkAll Stocks A–Z →